Sara Zborovski provides regulatory and commercial counsel to companies regulated by Health Canada. Her practice is largely focused on assisting clients navigate the regulatory regimes implemented by the Controlled Drugs and Substances Act, the Food and Drugs Act and the newly-introduced Cannabis Act and their respective regulations. Sara assists clients in the pharmaceutical, cannabis (marijuana and hemp), food & beverage and medical device industries. She has extensive experience advising companies on advertising and promotion, compliance policies, licensing and good manufacturing / production practices. Sara also works with clients on matters relating to product safety including crisis management and advocacy before the inspectorate and product recalls.
Sara has been advising companies in the cannabis space since the introduction of the MMPR in 2013 and has assisted in the preparation and filing of license applications, has advocated before Health Canada on behalf of numerous applicants and has advised on all aspects of the licensing, production, distribution, promotion and sale of medical and adult-use cannabis. Sara also acted as counsel to the Canadian Hemp Trade Alliance, advocating before Health Canada for change to the regulatory regime to permit whole plant use and is now engaged to advocate for the use of hemp-derived CBD in therapeutic and wellness products.